Labcorp Holdings Inc. LH
Labcorp Holdings Inc. (LH) is a leading global life sciences company that provides comprehensive diagnostic and drug development services. The company operates through two primary segments: Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics segment offers a wide range of clinical laboratory testing services, including standard tests like blood chemistry analyses and urinalyses, as well as advanced specialty testing in areas such as oncology, genetics, infectious diseases, and women's health. Labcorp serves healthcare providers, patients, employers, managed care organizations, and government programs through its extensive network of patient service centers and laboratories across North America, Europe, and other regions. The Biopharma Laboratory Services segment provides early development research, central laboratory services, and technology solutions to pharmaceutical, biotechnology, and medical device companies worldwide, supporting clinical trials and drug development from discovery through commercialization. Labcorp's business model combines diagnostic testing services for patient care with contract research services for the biopharmaceutical industry, leveraging technology-enabled platforms to deliver results efficiently and support healthcare decision-making.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.